when will 23 and me stock go on sale

by Dr. Morris Ledner DVM Published 3 years ago Updated 2 years ago

Soon enough, investors will be able to purchase more than just a DNA kit from the company. Via the use of a special purpose acquisition company (SPAC) that's owned and operated by Richard Branson, the billionaire founder of Virgin Group, 23andMe will become a publicly traded company in 2021.

Is 23andMe on the stock market yet?

It's been far from a smooth ride since 23andMe's stock market debut. The Silicon Valley-based genetics testing firm went public in June via a merger with a special acquisition company led by U.K. billionaire Richard Branson in a deal that raised nearly $600 million and boosted 23andMe's value to $3.5 billion.Dec 1, 2021

Why is 23andMe stock so low?

23andMe's stock has tumbled as a result of its weak revenue growth. New income from drug development collaborations could increase over time. It's difficult to value an enterprise that's in the midst of a pivot.Feb 16, 2022

Will 23andMe go public?

On June 17, 23andMe, which pioneered personalized medicine and at-home genetic testing kits 15 years ago, went public through a merger with a Richard Branson SPAC under the ME ticker and saw its share price rise by 21%, reflecting the market's interest in the potential of genetic analysis.Jun 20, 2021

Why did 23andMe get shut down?

The genetic testing company 23andMe announced today that it's relaunching its direct-to-consumer health testing kits after shutting them down two years ago when the Food and Drug Administration charged the company with failing to provide evidence that their tests were "analytically or clinically validated."Oct 21, 2015

Is 23andMe being shorted?

Short interest is the volume of 23andMe shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 30,490,000 shares of ME short. 16.35% of 23andMe's shares are currently sold short. Learn More on 23andMe's current short interest.

Is 23andMe profitable?

23andme is not making a profit at this time. Demand for home DNA testing has been falling and revenues have been decreasing. In January of 2020, 23andme had to lay off 15% of its workforce.

Who is 23andMe merging with?

VG Acquisition Corp.

23andMe going public at $3.5B via merger with Branson's blank check company. 23andMe is merging with VG Acquisition Corp., a special purpose acquisition company founded by billionaire Richard Branson, to go public. The deal values the consumer genetic testing company at $3.5 billion, including debt.

Is 23andMe owned by Google?

Google just took a $3.9 million stake in a biotech company called 23andMe Inc. The company was co-founded by Anne Wojcicki, who married Google co-founder Sergey Brin earlier this month.May 22, 2007

Who funded 23andMe?

GlaxoSmithKline invested $300 million in the company. In January 2022, this partnership was extended until July 2023 with an additional $50 million payment from GlaxoSmithKline. In January 2020, 23andMe announced it would lay off about 100 of its employees.

Why you shouldn't get a DNA test?

Privacy. If you're considering genetic testing, privacy may well be a concern. In particular, you may worry that once you take a DNA test, you no longer own your data. AncestryDNA does not claim ownership rights in the DNA that is submitted for testing.

Which is better 23&Me vs AncestryDNA?

The DNA matches you'll get from AncestryDNA are generally more accurate than the ones you may receive from 23andMe. AncestryDNA tends to yield more DNA matches for its users, but this is because their criteria are 6cMs per segment and also their database is bigger.

How many customers does 23andMe have?

23andMe has more than 12 million customers worldwide. Our Health + Ancestry Service allows individuals to acquire this information from the privacy of their own homes, without medical requisition.

Is 23andMe a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for 23andMe in the last year. There are currently 1 hold rating and 1...

When is 23andMe's next earnings date?

23andMe is scheduled to release its next quarterly earnings announcement on Thursday, May 12th 2022. View our earnings forecast for 23andMe .

How were 23andMe's earnings last quarter?

23andMe Holding Co. (NASDAQ:ME) announced its quarterly earnings data on Thursday, February, 10th. The company reported ($0.21) earnings per share...

What guidance has 23andMe issued on next quarter's earnings?

23andMe issued an update on its FY 2022 earnings guidance on Thursday, February, 24th. The company provided earnings per share guidance of for the...

What price target have analysts set for ME?

2 analysts have issued 12 month price objectives for 23andMe's shares. Their forecasts range from 6.00 to 11.00. On average, they expect 23andMe's...

Who are 23andMe's key executives?

23andMe's management team includes the following people: Ms. Anne Wojcicki , Co-Founder, CEO, Pres & Director Mr. Steven J. Schoch , CFO & Treas...

Who are some of 23andMe's key competitors?

Some companies that are related to 23andMe include Arena Pharmaceuticals (ARNA) , Legend Biotech (LEGN) , Intra-Cellular Therapies (ITCI) , Per...

What is 23andMe's stock symbol?

23andMe trades on the NASDAQ under the ticker symbol "ME."

Who are 23andMe's major shareholders?

23andMe's stock is owned by a number of institutional and retail investors. Top institutional investors include Revelation Capital Management LLC (...

When was 23andme created?

The vehicle became extremely popular in 2020 during the pandemic and set records, although interest has dimmed in 2021. 23andMe was founded in 2006 by Anne Wojcicki, Linda Avey and Paul Cusenza and offers individuals the chance to have their genes tested, providing them with information on health risks and ancestry.

What is 23andme DNA?

Shares of 23andMe, the consumer genetics company that offers a home DNA test kit, will start trading on Nasdaq later Thursday, under the ticker "ME." The company will hit public markets after merging with Richard Branson's special-purpose acquisition corporation, or SPAC, VG Acquisition Corp. VGAC, +3.19%. SPACs, or blank-check companies, raise money in an initial public offering and then have two years to acquire a business or businesses. The vehicle became extremely popular in 2020 during the pandemic and set records, although interest has dimmed in 2021. 23andMe was founded in 2006 by Anne Wojcicki, Linda Avey and Paul Cusenza and offers individuals the chance to have their genes tested, providing them with information on health risks and ancestry. Consumers can order one of the company's test kits, comprising a test tube for saliva collection that is then mailed to a laboratory for testing.

Is 23andme going public?

Consumer DNA-testing company 23andMe will go public by merging with VG Acquisition, a SPAC sponsored by Richard Branson's Virgin Group, The consumer DNA-testing company 23andMe will go public by merging with VG Acquisition VGAC, a special-purpose-acquisition company sponsored by Richard Branson's Virgin Group, a transaction ...

Where is 23andme located?

Located in Sunnyvale, Calif., 23andMe, which Wojcicki co-founded in 2006, provides direct-to-consumer genetic testing services. Customers provide saliva samples for analysis. The company's name is derived from the fact that a normal human cell includes 23 pairs of chromosomes.

Does23andMe Ever Go on Sale?

Believe it or not, 23andMe does offer some pretty incredible sales - usually around major holidays! To make it easy for our users to predict when 23 and Me does go on sale, the editors here at Genomelink have compiled all of the best sales that 23andMe has ever had.

The Best 23andMe Sale Events

The 23andMe sales below were compiled through historical records of 23andMe.com and contain all of the major coupon codes that 23andMe normally offers.

Forget 23andMe Discount Coupons - When to Buy Specific DNA Test Kits on Sale

With all the different deals, it can be a bit confusing when you should buy the different kits 23andMe has to offer. So, we’ll break it down for you!

We Got Your Back!

This article should save you a ton of time and effort in your search for the best deals on DNA testing kits from 23andMe. Did you know that after you get tested, you can use your raw DNA data to find out even more about yourself??

4 Green Flags for 23andMe's Future

As a genetic testing company, 23andMe Holding (NASDAQ: ME) is a futuristic business by default. There's nothing cooler than sending away a tube filled with your spit and getting (some of) the secrets of your genome unlocked and presented in a tidy report on your computer screen in return.

Is the Tech Stock Boom Over Forever?

Once high-flying stocks have continued to take a beating. One of the sectors where this has been the most apparent is in tech. In this segment of Backstage Pass recorded on Jan. 28, Fool contributors Jon Quast, Rachel Warren, Jason Hall, and Toby Bordelon talk about innovation.

23andMe Reports FY2022 Third Quarter Financial Results

Third quarter revenue of $57 million Therapeutics group advances first wholly-owned immuno-oncology antibody into clinical trials Vision of genetics-based primary care offers potential for millions of people to live healthier lives SUNNYVALE, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co.

7 Penny Stocks With the Biggest Chance of Blasting Off This Year

Penny stocks are a notoriously volatile stock class. And with inflation concerns growing worse by the month, penny stocks could feel like a bridge too far at the moment. Interest rates are rising, putting pressure on riskier asset classes in general. There’s little arguing that penny stocks are in prime position to spike currently.

23andMe to Report FY2022 Third Quarter Financial Results

SUNNYVALE, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that it will report financial results for the fiscal year 2022 (FY2022) third quarter after the market closes on Thursday, February 10, 2022.

Pennsylvania Capital Management Inc Buys Apple Inc, Berkshire Hathaway Inc, Meta Platforms ..

Investment company Pennsylvania Capital Management Inc (Current Portfolio) buys Apple Inc, Berkshire Hathaway Inc, Meta Platforms Inc, Realty Income Corp, Blackstone Inc, sells Invesco Financial Preferred ETF, Telefonaktiebolaget L M Ericsson, SPDR S&P Bank ETF, iShares U.S.

23andMe Announces Extension of GSK Collaboration and Update on Joint Immuno-oncology Program

GSK extends exclusive target discovery period of collaboration for a fifth year to discover and validate novel drug targets using 23andMe’s proprietary genetic and health survey database 23andMe elects for royalty option as GSK advances immuno-oncology antibody collaboration program targeting CD96 into development Company will discuss at its R&D Day event today at 8:00 a.m.

How much money does 23andme get?

As part of its merger with VGAC, 23andMe will get cash proceeds of $759 million, which includes $509 million from the SPAC's trust account and another $250 million as PIPE (private investment in public equity) at $10 per share. 23andMe will use the money for growth.

How much revenue will 23andme have in 2024?

In 2024, 23andMe forecasts revenue of $400 million and a gross margin of 58 percent, compared with $247 million and 45 percent in 2021. By 2024, the company hopes to have more than 16 million customers. Article continues below advertisement.

How much will genetic testing grow in 2025?

Between 2025 and 2027, the global genetic testing market is expected to grow 11.5 percent compounded annually to reach $23 billion. It's difficult to forecast ME stock's short-term price action because it will depend a lot on investor sentiment.

What does it mean to sign up for 23andme?

Is 23andme safe?

At 23andMe, sign up doesn’t just mean you’ll receive their award-winning service, but it also means that your information will always be kept safe. You are always in control and can choose how your personal genetic information is used and shared; they will never share your data without your explicit consent. With heavy security measures such as external firewalls, separate databases, and encrypted connections, your identity is carefully monitored and will never be released.